Global Oncology Academy

Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
AudioAbstracts
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
- Ryan Quigley
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Global Oncology Academy
Prioritizing Quality of Life in CRC: Key Surgical Considerations
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CE
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
0.25 credits
- Charles E. Geyer Jr., MD, FACP
- Komal Jhaveri, MD, FACP
0.25 credits
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
- Ryan Quigley
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Project Oncology®
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
- Pavani Chalasani, MD, MPH
- Virginia Borges, MD
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Does BMI Matter in mBC Outcomes?
Does BMI Matter in mBC Outcomes?
Project Oncology®
Does BMI Matter in mBC Outcomes?
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast Cancer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
- Charles Turck, PharmD, BCPS, BCCCP
- Heather Parsons

Medical News

Medical News
Localized IL-15 Immunotherapy with a Delayed-Release Implant for Glioblastoma
02/05/2026
Read more
Medical News
Epigenetic Instability and Liquid Biopsy: Rethinking Early Cancer Detection
02/04/2026
Read more
Medical News
Mechanistic Insights into TP53 Inactivation and SCD1 Upregulation Driving Brain Metastasis in Breast Cancer
02/02/2026
Read more
Medical News
Revolutionizing Cancer Therapy: The Impact of Macrophage-Targeting Immunotherapy
02/02/2026
Read more

See more news

CME/CE

Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
1.00 credit
- Ryan D. Cassaday, MD
- Daniel J. DeAngelo, MD, PhD
1.00 credit
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program credit
- A.J. Gelderblom, MD, PhD
- Michiel van de Sande, MD, PhD
1.00 program credit
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
MinuteCE®
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
1.00 program credit
- Michiel van de Sande, MD, PhD
1.00 program credit
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
MinuteCE®
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit

Clinical Practice

Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Global Oncology Academy
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
- Jennifer Caudle, DO, FACOFP
- Mansi R. Shah, MD
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Advancing HER2-Targeted Therapy in GI Cancers
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®
Advancing HER2-Targeted Therapy in GI Cancers
- John H. Strickler, MD

Programs

Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
- Maxwell Llyod, MD
- Ryan Quigley
Bridging Gaps with Blood-Based CRC Screening
Bridging Gaps with Blood-Based CRC Screening
Global Oncology Academy
Bridging Gaps with Blood-Based CRC Screening
- Ryan Quigley
- Aasma Shaukat, MD, MPH
How AI Is Transforming Biomarker Development in GI Oncology
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®
How AI Is Transforming Biomarker Development in GI Oncology
- William Hall, MD
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
Project Oncology®
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
- Pavani Chalasani, MD, MPH
- Alison Stopeck, MD